Monthly mandatory surveillance of MRSA, MSSA, Gram-negative bacteraemia and C. difficile infections, June 2025 to June 2026
Mandatory surveillance of healthcare-associated infections (HCAI), which include methicillin-resista...
Publisher
UK
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- UK Health Security Agency
- Region
- UK
- Scope
- Regulatory
- Published
- July 23, 2026
- Language
- EN
Topics
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
Mandatory surveillance of healthcare-associated infections (HCAI), which include methicillin-resista...
Source route
Continue on gov.uk
Leave the platform to read the original full article on the publisher site.
Source: UK Health Security Agency
Scope: Regulatory
Related coverage
More related coverage
Medicines eligible for Northern Ireland MHRA Authorised Route
Sets out medicines that can be moved to Northern Ireland to meet patient need.
High consequence infectious disease: country specific risk
Listing of countries with a known occurrence of high consequence infectious disease (HCID).
Ebola and Marburg haemorrhagic fevers: outbreaks and case locations
Information about incidents and outbreaks of Ebola and Marburg, both viral haemorrhagic fevers (VHF)...
Outbreaks under monitoring in 2026
Latest information on global disease events under monitoring.